World's Best Scientists 2026 revealed!
Franki Speleman

Franki Speleman

Award Badge
Genetics
Belgium
2026

D-Index & Metrics

Genetics

D-Index
108
Citations
67898
World Ranking
558
National Ranking
5

Research.com Recognitions

  • 2026 - Research.com Genetics in Belgium Leader Award
  • 2025 - Research.com Genetics in Belgium Leader Award
  • 2024 - Research.com Genetics in Belgium Leader Award
  • 2023 - Research.com Genetics in Belgium Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • DNA

Franki Speleman mostly deals with Genetics, Cancer research, Neuroblastoma, Gene and Molecular biology. His Cancer research research is multidisciplinary, relying on both Carcinogenesis, microRNA, Chromosomal rearrangement and Immunology. His research in Neuroblastoma intersects with topics in Oncology, Pathology, Internal medicine, Survival analysis and Loss of heterozygosity.

His research investigates the connection between Molecular biology and topics such as Regulation of gene expression that intersect with problems in Transcriptome. Franki Speleman has included themes like Microarray analysis techniques, Real-time polymerase chain reaction and Computational biology in his Gene expression profiling study. His studies in Microarray analysis techniques integrate themes in fields like Housekeeping gene and Proportional hazards model.

His most cited work include:

  • Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes (14653 citations)
  • qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data (2808 citations)
  • Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma (409 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Cancer research, Genetics, Neuroblastoma, Gene and Molecular biology. His work investigates the relationship between Cancer research and topics such as microRNA that intersect with problems in Gene silencing. His studies examine the connections between Neuroblastoma and genetics, as well as such issues in Pathology, with regards to Internal medicine.

The concepts of his Gene study are interwoven with issues in Computational biology and Cell biology. His study looks at the relationship between Molecular biology and fields such as Cytogenetics, as well as how they intersect with chemical problems. Franki Speleman has researched Gene expression in several fields, including RNA and Real-time polymerase chain reaction.

He most often published in these fields:

  • Cancer research (30.84%)
  • Genetics (29.67%)
  • Neuroblastoma (28.74%)

What were the highlights of his more recent work (between 2015-2021)?

  • Cancer research (30.84%)
  • Neuroblastoma (28.74%)
  • Cell biology (8.64%)

In recent papers he was focusing on the following fields of study:

Franki Speleman focuses on Cancer research, Neuroblastoma, Cell biology, Gene and Computational biology. His Cancer research research is multidisciplinary, incorporating perspectives in Genetics, Leukemia, Signal transduction, Gene knockdown and Non invasive. Franki Speleman is interested in Long non-coding RNA, which is a branch of Genetics.

His Neuroblastoma study combines topics in areas such as Phenotype, Circulating Cell-Free DNA, Downregulation and upregulation, FOXM1 and Epigenetics. His research on Gene frequently connects to adjacent areas such as Cell growth. His Computational biology course of study focuses on Zebrafish and Real-time polymerase chain reaction.

Between 2015 and 2021, his most popular works were:

  • A mechanistic classification of clinical phenotypes in neuroblastoma (74 citations)
  • Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients (55 citations)
  • Long noncoding RNA expression profiling in cancer: Challenges and opportunities. (54 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

His scientific interests lie mostly in Cancer research, Neuroblastoma, Gene, microRNA and RNA. His Cancer research research integrates issues from Molecular biology, Stem cell, N-Myc, FOXM1 and Leukemia. His Neuroblastoma study integrates concerns from other disciplines, such as Viability assay, Regulation of gene expression and Pharmacology.

His study ties his expertise on Computational biology together with the subject of Gene. The Computational biology study combines topics in areas such as Three prime untranslated region, Real-time polymerase chain reaction, Zebrafish and Gene expression profiling. MicroRNA is a subfield of Genetics that Franki Speleman investigates.

Best Publications

  • Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

    Jo Vandesompele;Katleen De Preter;Filip Pattyn;Bruce Poppe

  • qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data

    Jan Hellemans;Geert Mortier;Anne De Paepe;Franki Speleman

  • miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

    Li Ma;Jennifer Young;Harsha Prabhala;Elizabeth Pan

  • Identification of ALK as a major familial neuroblastoma predisposition gene

    Yaël P. Mossé;Marci Laudenslager;Luca Longo;Kristina A. Cole

  • A novel and universal method for microRNA RT-qPCR data normalization

    Pieter Mestdagh;Pieter Van Vlierberghe;An-Sofie De Weer;Daniel Muth

  • Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.

    Catherine Dodé;Jacqueline Levilliers;Jean-Michel Dupont;Anne De Paepe

  • Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes

    Heather C Mefford;Andrew J Sharp;Carl Baker;Andy Itsara

  • Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

    N Bown;S Cotterill;M Lastowska;S O'Neill

  • RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer

    Andrew L Wolfe;Kamini Singh;Yi Zhong;Philipp Drewe

  • Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.

    Ludwine M. Messiaen;Tom Callens;Geert Mortier;Diane Beysen

  • Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations.

    Yao-Cheng Lin;Morgane Boone;Leander Meuris;Irma Lemmens

  • EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts

    Jessica Zucman;Olivier Delattre;Chantal Desmaze;Alan L. Epstein

  • Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis.

    Jan Hellemans;Olena Preobrazhenska;Andy Willaert;Philippe Debeer

  • International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

    PF Ambros;IM Ambros;GM Brodeur;M Haber

  • LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression

    Jan J Molenaar;Raquel Domingo-Fernández;Marli E Ebus;Sven Lindner

  • Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports

    B. Menten;N. Maas;B. Thienpont;K. Buysse

  • Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma

    Isabelle Janoueix-Lerosey;Gudrun Schleiermacher;Evi Michels;Véronique Mosseri

  • High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA

    Pieter Mestdagh;Tom Feys;Nathalie Bernard;Simone Guenther

  • The miR-17-92 MicroRNA Cluster Regulates Multiple Components of the TGF-β Pathway in Neuroblastoma

    Pieter Mestdagh;Anna-Karin Bostrom;Francis Impens;Erik Fredlund;Erik Fredlund

  • Mutational dynamics between primary and relapse neuroblastomas

    Alexander Schramm;Johannes Köster;Johannes Köster;Yassen Assenov;Kristina Althoff

Frequent Co-Authors

Jo Vandesompele
Jo Vandesompele Ghent University
Katleen De Preter
Katleen De Preter Ghent University
Nadine Van Roy
Nadine Van Roy Ghent University
Anne De Paepe
Anne De Paepe Ghent University Hospital
Bruce Poppe
Bruce Poppe Ghent University Hospital
Genevieve Laureys
Genevieve Laureys Ghent University Hospital
Pieter Mestdagh
Pieter Mestdagh Ghent University
Björn Menten
Björn Menten Ghent University Hospital
Johannes H. Schulte
Johannes H. Schulte Charité - University Medicine Berlin
Rogier Versteeg
Rogier Versteeg University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Genetics can open doors to diverse careers in healthcare and research. For those interested in patient care and medical innovation, online nursing degrees offer flexible ways to expand your expertise. If you are already a registered nurse, advancing your education through online rn to bsn programs allows you to enhance your qualifications and leadership skills.

Taking the next step, a online nurse practitioner program can prepare you for advanced practice roles in specialty areas, including genetics counseling or clinical research. For those eager to lead in healthcare systems, the best dnp programs online emphasize evidence-based practice and organizational leadership.

Many professionals begin their journey with a online nursing degree, making it a widely accessible entry point into healthcare and research careers. No matter which online pathway you choose, integrating genetics knowledge with a nursing background can provide a competitive advantage in the rapidly evolving world of healthcare.

Best Scientists Citing Franki Speleman

Trending Scientists